05.12.2024 14:34:45
|
EQS-Adhoc: Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share
EQS-Ad-hoc: Marinomed Biotech AG / Key word(s): Corporate Action/Capital Increase Korneuburg, Austria, December 5, 2024 - Marinomed Biotech AG (the “Company”) announces that the Management Board has resolved today to increase the Company's share capital again by EUR 83,750 to EUR 1,778,333 by issuing 83,750 new no-par value bearer shares against cash contributions (the “Second Capital Increase”). The new shares will be issued from the authorized capital 2024 under exclusion of statutory subscription rights of existing shareholders. A report on the intended exclusion of the subscription rights of existing shareholders (the “Report”) was published on the Company's website from November 28, 2024 onwards, and on the electronic announcement and information platform of the Federal Government of Austria ("EVI") on November 28, 2024. The issue price per new share is EUR 8 so that the total issue price amounts to EUR 670,000. The required Supervisory Board resolution for the Second Capital Increase under exclusion of statutory subscription rights can be passed no earlier than two weeks after publication of the Report. The Company had already provided information on a possible second capital increase in ad hoc announcements of September 2, September 15, September 18 and November 27, 2024.
All 83,750 new shares have been subscribed by a total of nine individually approached investors at these issue terms and conditions. +++ End of ad-hoc announcement +++ End of Inside Information
05-Dec-2024 CET/CEST News transmitted by EQS Group AG. www.eqs.com |
Language: | English |
Company: | Marinomed Biotech AG |
Hovengasse 25 | |
2100 Korneuburg | |
Austria | |
Phone: | +43 2262 90300 |
E-mail: | office@marinomed.com |
Internet: | www.marinomed.com |
ISIN: | ATMARINOMED6 |
WKN: | A2N9MM |
Listed: | Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt, Munich, Stuttgart, Tradegate Exchange; Vienna Stock Exchange (Official Market) |
EQS News ID: | 2045241 |
End of Announcement | EQS News Service |
|
2045241 05-Dec-2024 CET/CEST
Nachrichten zu Marinomed Biotech AG
15:58 |
Starker Wochentag in Wien: ATX Prime mit Zuschlägen (finanzen.ch) | |
12:26 |
Freundlicher Handel: ATX Prime zeigt sich am Dienstagmittag fester (finanzen.ch) | |
09:28 |
Gewinne in Wien: ATX Prime zeigt sich zum Start fester (finanzen.ch) | |
13.01.25 |
Optimismus in Wien: ATX Prime klettert letztendlich (finanzen.ch) | |
13.01.25 |
Börse Wien in Rot: So bewegt sich der ATX Prime aktuell (finanzen.ch) | |
13.01.25 |
Angespannte Stimmung in Wien: So steht der ATX Prime aktuell (finanzen.ch) | |
13.01.25 |
ATX Prime aktuell: ATX Prime verbucht zum Handelsstart Gewinne (finanzen.ch) | |
10.01.25 |
Freundlicher Handel: ATX Prime zum Ende des Freitagshandels mit Gewinnen (finanzen.ch) |
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
NEU✅ Wolters Kluwer
NEU✅ American Express
NEU✅ Deckers Outdoor
inklusive Rebalancing:
❌ Synopsys
❌ Vertex Pharmaceuticals Inc
❌ Targa Resources
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Meistgelesene Nachrichten
Börse aktuell - Live Ticker
Hoffnung auf schrittweise Zollerhöhung durch Trump: SMI beendet Handel stabil -- DAX letztlich höher -- Wall Street letztlich gespalten -- Börsen in Asien schliessen uneinheitlichDer heimische Aktienmarkt schloss am Dienstag wenig bewegt. Der deutsche Aktienmarkt zeigte sich mit Gewinnen. Die US-Börsen notierten uneins. An den Märkten in Asien ging es am Dienstag uneinheitlich zu.